·2,447,543篇论文数据，部分数据来源于NoteExpress
Symphony GenIsis is likely to own the drug candidates for about four years.
FORBES: Biotech's Financial Lifeline
With Isis, Symphony and some co-investors are creating a new entity, Symphony GenIsis, that will take ownership of a promising cholesterol-lowering drug candidate in Isis' pipeline through its Phase 2b trials.
应用推荐
模块上移
模块下移
不移动